换一批
换一批Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats.
第一作者：
Rasool,Haddadi
第一单位：
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
作者：
主题词
动物(Animals);消炎药(Anti-Inflammatory Agents);僵住症(Catalepsy);纹状体(Corpus Striatum);细胞因子类(Cytokines);剂量效应关系, 药物(Dose-Response Relationship, Drug);白细胞介素6(Interleukin-6);男(雄)性(Male);神经保护药(Neuroprotective Agents);羟多巴胺(Oxidopamine);帕金森障碍(Parkinsonian Disorders);过氧化物酶(Peroxidase);大鼠(Rats);大鼠, Wistar(Rats, Wistar);水飞蓟素(Silymarin);肿瘤坏死因子α(Tumor Necrosis Factor-alpha)
DOI
10.1016/j.neulet.2013.09.022
PMID
24045063
发布时间
2013-11-15
- 浏览0
Neuroscience letters
106-11页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
